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Abstract We have identified from rat kidney a novel isoform of 
ROMKIKirl.1, designated ROMK6IKirl.lf. ROMK6 was 
nearly identical to ROMKl, but possessed an 122-bp insertion 
in the 5’ region. Its deduced amino acid sequence was shorter by 
19 amino acids than that of ROMKl in the amino-terminus. 
Unlike other previously reported ROMK isoforms, ROMKB 
mRNA was ubiquitously expressed in various tissues, including 
kidney, brain, heart, liver, pancreas and skeletal muscle. 
Xenopus oocytes injected with ROMK6 cRNA expressed a 
Ba*+-sensitive weakly inwardly rectifying K+ current. These 
results indicate that ROMK6 is a novel functional K+ channel 
and might be involved in K+ secretion in various tissues. 
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1. Introduction 
Inwardly rectifying K+ channels play significant roles in 
controlling excitability and secretion of K+ ions in various 
types of cells. The first cDNA encoding an inwardly rectifying 
K+ channel has been isolated from rat renal outer medulla by 
expression cloning [l] and designated ROMKl (Kirl.la). Im- 
munohistochemical analyses showed that ROMKl protein 
was localized to the apical membrane of renal cortical collect- 
ing duct epithelial cells [2]. ROMKl expressed in Xenopus 
oocytes forms a weakly inwardly rectifying K+ channel cur- 
rent with a single channel conductance of 3545 pS with 90 
mM extracellular K+. The channel requires intracellular Mg- 
ATP to open, exhibits a high open probability at various 
potentials, and is inhibited by intracellular Hf. These proper- 
ties are comparable to those of the low-conductance Kf chan- 
nel electrophysiologically identified in the apical membrane of 
cortical collecting duct cells [ 1,3-Q 
Recent studies have shown that the human ROMK gene is 
composed of at least five exons, while exon 3 has not been 
reported in the rat ROMK gene, and produces divergent 
mRNAs as a result of alternative splicing at their 5’ regions 
[9-111. So far, five isoforms of ROMK mRNAs in human 
have been identified and designated ROMKl-5 (Kirl.1a-e) 
[9,12]. In rat, so far, three isoforms (ROMKl-3) have been 
isolated [13]. This divergence of ROMK mRNAs may result 
in the formation of channel subunit proteins with variable 
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lengths of amino (N)-termini. It was also shown that these 
ROMK isoforms were differentially expressed among different 
segments of renal tubules [13], where they might play distinct 
roles in controlling K+ secretion. 
In the present study, we have tried to find a new member of 
the ROMK family from rat kidney, using the RT-PCR clon- 
ing technique. We have identified a novel ROMK isoform and 
designated it ROMK6 (Kirl.lf). ROMK6 expressed a weakly 
inwardly rectifying K+ current in Xenopus oocytes. Unlike 
other previously reported ROMK isoforms, its mRNA was 
ubiquitously expressed in various tissues including kidney, 
brain, heart, liver, pancreas and skeletal muscle. Thus, 
ROMK6 might be involved in K+ secretion in various tissues. 
2. Materials and methods 
2.1. Isolation of cDNAs encoding ROMK channel 
Total RNA prepared from whole rat kidney was reverse transcribed 
using an oligo-(dT) primer. The resulting cDNA was amplified by 
PCR using a sense primer (nucleotides -87 to -67 in rat ROMKl; 
5’-GCTTAAGATTCATTAAGGTGG-3’) paired with an antisense 
primer (nucleotides 11741194; S-TAGGTGGAAAAGCCACTGC- 
TA-3’). The PCR conditions were as follows: an initial denaturation 
at 94°C for 4 min, followed by 25 cycles of denaturation at 94°C for 
1 min, annealing at 62°C for 1 min, and extension at 72°C for 1 min, 
with a final extension step at 72°C for 8 min. The amplified fragments 
were subcloned into pBluescript II SK-plasmid (Stratagene, La Jolla, 
CA), and sequenced on both strands using a DNA sequencer (DSQ- 
1000, Shimadzu, Kyoto, Japan). 
2.2. Functional expression in Xenopus oocytes and electrophysiological 
measurements 
Each plasmid was linearized by digestion with KpnI and capped 
cRNAs prepared with T3 RNA polymerase using a mCAP RNA 
capping kit (Stratagene). Manually defolliculated oocytes were in- 
jected with cRNAs dissolved in water (50 nl of 500 ng/pl). For con- 
trol, the same volume of sterile water was injected. After injection, 
oocytes were incubated in ND96 solution at lS”C, and electrophysio- 
logical studies were undertaken 48-96 h later. Two-electrode voltage 
clamp experiments were carried out with an amplifier (Turbo Clamp 
TEC OlC, Tamm, Germany) using microelectrodes filled with 3 M 
KCl. Oocytes were bathed in a solution which contained 90 mM KCl, 
3 mM MgCls, 5 mM HEPES, pH 7.4, and 300 pM niflumic acid to 
block endogenous chloride current. Oocytes were voltage-clamped at 
0 mV and voltage steps of 1.2 s duration from - 120 to +60 mV in 20- 
mV increments were applied to the cells every 5 s. Results were ex- 
pressed as mean f SE. 
2.3. Tissue distribution of rat ROMK isoforms 
Distribution of ROMK isoforms in different rat tissues was deter- 
mined by RT-PCR. Total RNAs from various organs were extracted 
by the guanidine thiocyanate method and were reverse transcribed 
using an oligo-(dT) primer. The resulting cDNAs were amplified 
in the PCR using a ROMK-specific sense primer (nucleotides 13-30 
in rat ROMKl ; 5’-GAACGGAGTGTGTTCAGA-3’) paired with 
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an antisense primer (nucleotides 536553; 5’-GTCTAGAGATCTT- 
GGCTA-3’). The RT-PCR products were then amplified by second 
PCR using a sense primer (nucleotides 18-35; 5’-GAGTGTGTTCA- 
GAGT@T-3’) and an antisense primer (nucleotides 218-237; 5’- 
GTACCTCCATTTCAGGTCCA-3’). Amolified fraements were elec- 
I I 
trophoretically fractionated on 2% agarose gels. RT-PCR products 
from kidney and skeletal muscle were subcloned into pCR vector 
(Invitrogen, San Diego, CA), and were sequenced as described above 
to confirm the sequences of an ROMK isoform. 
3. Results 
The RT-PCR using the primers for ROMKI (see Section 2) 
of rat kidney total mRNAs yielded two transcripts of 1281 bp 
and 1403 bp. The transcript of 1403 bp was less visible than 
that of 1281 bp. The sequence analysis showed that the clone 
of 1281 bp was identical to rat ROMKl except for three bp 
substitutions at nucleotide positions 235, 555 and 1104. All of 
them were C in rat ROMKl [l], and T in the 1281-bp clone. 
The same substitutions at corresponding sites were also de- 
tected in the 1403-bp clone. These substitutions might be due 
to gene polymorphism in rat ROMK gene, but did not cause 
any alteration in the deduced amino acid sequence of the 
1281-bp clone from that of rat ROMKl. Such substitutions 
have also been demonstrated between rat ROMKZ and 
ROMK2b [13]. 
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The 1403-bp clone had an 122-bp insertion in the 5’-region 
between the nucleotides at positions 36 and 37 in rat ROMKl 
(Fig. 1A). None of ROMK isoforms reported so far contained 
this 122-bp fragment in their nucleotide sequences. Therefore, 
we considered this 1403-bp clone to be a novel isoform of 
ROMKs and designated it rat ROMK6 (Kirl.lf). This result 
suggests that a novel exon which has not been identified ear- 
lier exists in ROMK gene. 
The putative structure of the ROMK gene expected from 
previous and present studies on the ROMK isoforms [1,9-l l] 
is depicted in Fig. 1B. The previous studies have indicated 
that the human ROMK gene is composed of five exons: 
four exons (exons 14) in the 5’-end and the core exon in 
the 3’-end. The present study suggests that a novel exon 
(exon 5) exists between exon 4 and the core exon in the rat 
ROMK gene. This exon has not been identified in the human 
ROMK gene. Thus, it might be specific to the rat gene. Be- 
cause exon 3 in human ROMK gene has not been reported in 
the rat gene, ROMK genes both in human and rat may be 
composed of at least five exons: i.e. exons 14 and the core 
exon in human, and exon 1, exon 2, exon 4, exon 5 and the 
core exon in rat (Fig. 1B). The additional 122-bp segment 
found in rat ROMK6 mRNA, which may be derived from 
exon 5, can introduce an in-frame stop codon upstream of the 
ATG in the core exon of rat ROMK isoforms as indicated by 
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Fig. 1. Nucleotide and deduced amino acid sequences of rat ROMK cDNAs. (A) Aligned nucleotide and deduced amino acid sequences in the 
5’-region of rat ROMKl and rat ROMK6. The nucleotides of ROMKl and ROMK6 are numbered to the right of each sequence. The termi- 
nation codon is double underlined. The nucleotide sequences of sense and antisense primers for RT-PCR to determine tissue distributions of 
ROMKl and ROMK6 mRNAs are underlined. ROMK6 has a nucleotide sequence identical to ROMKl and possesses an additional 122-bp 
insertion, which is shaded, in the N-terminal region between nucleotide positions 36 and 37 in ROMKl. The insertion of 122 bp introduces an 
in-frame stop codon upstream of the ATG in the core exon of ROMK isoforms as indicated by the double bars. (B) The putative structure of 
rat and human ROMK genes encoding ROMK6 and previously reported ROMK isoforms. ROMK6 may possess a novel exon (exon 5) be- 
tween exon 4 and a common core exon of ROMK isoforms. (C) N-terminal amino acid sequences in rat or human ROMK isoforms. The start 
of common amino acid sequences is shaded. ROMK6 would not contain the first 19 amino acids present in the rat ROMKl protein. 
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Fig. 2. Functional expression of rat ROMKl and ROMK6 in Xenopus oocytes. Representative current records from Xenopus oocytes injected 
with Hz0 (A), ROMKl cRNA (B) or ROMK6 cRNA (C) in 90 mM KC1 solution without (first column) and with 1 mM BaCls (second col- 
umn) are shown, The steady-state current-voltage relationships of these currents in solutions without Ba2+ (closed circles) and with 1 mM Ba2+ 
(open circles) are shown in the third column. Both ROMKI and ROMK6 exhibited a weak inwardly rectifying profile, which was not observed 
in HzO-injected oocytes. These inward currents were almost completely inhibited by 1 mM Ba’+. 
the double bars in Fig. 1A. Consequently, the deduced amino 
acid sequence of rat ROMK6 would be shorter by 19 amino 
acids than that of rat ROMKl in the N-terminus and thus 
would be the same as those of rat and human ROMK2 and 
human ROMK4, 5 (Fig. 1C). 
Representative membrane currents recorded from Xenopus 
oocytes injected with Hz0 (A), rat ROMKl cRNA (B) or 
ROMK6 cRNA (C) are shown in Fig. 2. ROMK6 as well 
as ROMKl currents exhibited weakly inwardly rectifying 
K+ currents, which were never observed in HzO-injected oo- 
cytes. In both cases of ROMKl and ROMK6, Ba2+ (1 mM) 
added to the bathing solution blocked the inward currents 
almost completely, but hardly affected the outwardly going 
currents at depolarized potentials. The Ba2+-sensitive currents 
at -120 mV at the end of the voltage steps were 8.27f0.23 
pA (n = 18) in the oocytes injected with ROMKl cRNA and 
6.67 f 0.26 pA (n = 6) in those with ROMK6 cRNA. 
To determine tissue distributions of ROMKl and ROMK6 
mRNAs, RT-PCR assay was performed (Fig. 3). The specific 
primers for amplification of both ROMKl and ROMK6 were 
designed to yield transcripts of 220-bp for ROMKl and 342- 
bp for ROMK6. Thus, in the tissues where both ROMKl and 
ROMK6 mRNAs are expressed, two transcripts of 220 bp 
and 342 bp can be detected. As shown in Fig. 3, ROMKl 
mRNA was expressed mainly in kidney and spleen, and 
slightly in brain, eye, small intestine, colon and testis. On 
the other hand, ROMK6 mRNA distributed not only in these 
tissues but also in all other tissues examined: atrium, ventri- 
cle, lung, liver, pancreas and skeletal muscle. RT-PCR pro- 
ducts with expected lengths of ROMK6 from kidney and 
skeletal muscle were sequenced, and the presence of the 
ROMK6 specific 122-bp splice was confirmed (data not 
shown). 
4. Discussion 
A major difference between ROMK6 and ROMKl in rat 
was their tissue distribution. It has been reported that ROMK 
isoforms are predominantly expressed in kidney of both rat 
and human by Northern blot analysis [9-l 11. The distribution 
of other rat ROMK isoforms (ROMK2 and ROMK3) was 
shown to be different from that of rat ROMKl within kidney, 
but has not been examined in other tissues [13]. In human 
tissues, Shuck et al. [9] performed the RT-PCR assay using 
sense primers specific for either exon 1, exon 2, exon 4 or the 
core exon paired with a common antisense primer (core exon- 
specific), and showed that the amplicon derived from exon 1 
was only expressed in kidney, that from exon 2 in kidney, 
brain and heart, that from exon 4 in kidney and pancreas, 
and that from the core exon in all tissues examined: brain, 
heart, kidney, liver, skeletal muscle, pancreas and spleen. 
However, the distribution of exon 3, the human-specific 
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Fig. 3. RT-PCR detection of rat ROMKl and ROMK6 mRNAs. 
The RT-PCR assay was performed as described in Section 2. The 
RT-PCR yielded visible amplified product (220 bp) of ROMKl in 
mRNA of brain, eye, spleen, small intestine, colon, kidney and tes- 
tis, and that (342 bp) of ROMK6 in mRNA of all tissues examined 
in this study as follows: brain, eye, atrium, ventricle, lung, liver, 
spleen, pancreas, small intestine, colon, kidney, skeletal muscle and 
testis. 
exon, has not been examined. On the other hand, we found 
that the amplicon corresponding to ROMKl (complex of 
exon 4 and the core exon) was detected in rat kidney, spleen 
and brain but not in pancreas, and that corresponding to 
ROMK6 (complex of exon 4, exon 5 and the core exon) 
was detected in all rat tissues examined. The novel exon 
(exon 5) found in ROMK6 has not been reported in the hu- 
man ROMK gene, while exon 3 reported in the human 
ROMK gene has not been identified in the rat ROMK gene 
[9,10]. Thus, the structure of the ROMK gene may differ 
between rat and human. The different structure of the 
ROMK gene between rat and human may underlie the differ- 
ent tissue distribution of the various ROMK isoforms in these 
species. 
RT-PCR for ROMK6 mRNA indicated that this clone is 
ubiquitously expressed in various rat tissues, whereas rat 
ROMKl and human ROMK isoforms (ROMKl, ROMK2 
and ROMK3) are expressed in limited tissues. Therefore, un- 
like other previously reported ROMK isoforms, ROMK6 
might be involved in K+ secretion not only in kidney but 
also in other tissues. Ubiquitous distribution of ROMK6 
may also indicate the possibility that this clone expresses in 
such subsets of cells that distribute widely in various tissues, 
e.g. vascular smooth muscle, endothelial, epithelial and per- 
ipheral nerve cells. 
The insertion of exon 5 introduced an in-frame stop codon 
upstream of the ATG within a Kozak sequence [14] in the 
core exon of ROMK isoforms. Consequently, the deduced 
protein of ROMK6 is identical to that of rat ROMK2, but 
is 19 and 26 amino acids shorter than those of rat ROMKl 
and rat ROMK3, respectively. Human ROMK2, ROMK4 
and ROMKS also basically produce the same protein as rat 
ROMK2 and ROMK6 (Fig. lB,C). Previous studies indicated 
that these variations in the N-terminal ends affect neither ion 
permeation nor channel gating in both human and rat 
[9,11,13]. Consistently, the K+ currents in Xenopus oocytes 
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induced by ROMK6 cRNA showed similar properties to 
those by ROMKl. Distributions but not electrophysiological 
properties are different among ROMK isoforms, suggesting 
that physiological roles of ROMK isoforms may be mainly 
dependent on their tissue distribution. Because ROMK6 is the 
only one which distributes ubiquitously, this clone might be 
unique to be involved in K+ secretion in a wide variety of 
tissues, while other ROMK isoforms may play significant 
roles mainly in kidney. 
It has been shown that expression of rat ROMKl with a 
sulfonylurea receptor (SUR), a member of the ATP-binding 
cassette (ABC) superfamily, in Xenopus oocytes conferred sen- 
sitivity to sulfonylureas, such as tolbutamide, on rat ROMKl 
currents [15]. In addition, McNicholas et al. [16] reported that 
coexpression of rat ROMK2 and the cystic fibrosis transmem- 
brane regulator (CFTR), another member of the ABC super- 
family, significantly enhanced the sensitivity of rat ROMK2 to 
the sulfonylureas, and concluded that ROMK2 and CFTR 
may reconstitute the main characteristic feature of epithelial 
type ATP-sensitive K+ channels. If the CFTR/ROMK2 com- 
plex is the epithelial ATP-sensitive K+ channels, ROMK2 
should be expressed in all tissues containing epithelial cells. 
ROMK2, however, is expressed in a limited number of tissues 
at least in human, while CFTR is expressed in various epithe- 
lial cells including those of kidney, lung, pancreas and gastro- 
intestinal tract of both human and rat [17-191. Therefore, 
ROMK2 cannot be always the partner of CFTR to form 
the epithelial ATP-sensitive K+ channels. Because rat 
ROMK6 has the deduced protein identical to that of rat 
ROMK2 and was expressed ubiquitously among various tis- 
sues, this clone might be a better candidate associated with 
CFTR to form the epithelial ATP-sensitive K+ channels at 
least in rat. Further studies are needed to elucidate this pos- 
sibility and other functional roles of ROMK6 in vivo. 
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